Purchase Order 75N91024P00538
Award Date 9/16/24
Potential Completion Date 3/31/25
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a $554,309.88 firm-fixed price definitive contract awarded by the National Cancer Institute (NCI) to CN Consulting LLC, a self-certified small disadvantaged, woman-owned small business. The contract is for subject matter expert services in support of NCI's Cancer Moonshot program, with a period of performance ending on September 15, 2024. The contract was awarded on September 16, 2020 and does not have a set-aside designation.</p>
- <p>The National Cancer Institute issued a purchase order to National Cancer Center, National Research and Development Agency on May 14, 2026, with a ceiling value of $15,075.00 for firm fixed price commercial items. This order replaces PO 75N91021P00879 to correct the UEI number. Work is performed in Bethesda, Maryland, with an ultimate completion date of May 13, 2027.</p>
- Leidos Biomedical Research Inc., a Federally Funded Research and Development Center (FFRDC) subsidiary of Leidos Holdings, Inc., was awarded a delivery order valued at $19.76 million by the National Cancer Institute on September 28, 2017, for the Retrospective Tumor Characterization Analysis (Moonshot) initiative. This cost-plus-fixed-fee delivery order, with an ultimate completion date of September 30, 2026, supports the National Cancer Institute's cancer research mission and will be...
- The National Cancer Institute awarded a $2.3M firm fixed-price definitive contract to Synbal, Inc., a small business, on September 18, 2018, for the development and validation of non-mouse reagents to enable preclinical development of novel therapeutics under the Cancer Moonshot Initiative. The contract, designated as a total small business set-aside, supports the FY26 Underpinning Data Outreach (UDO) Initiative pursuant to Executive Order 14042. Work will be performed at the contractor's...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled "Non-Invasive Subtyping of Aggressive Tumor and Its Environment" as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC...
- The National Cancer Institute, a civilian agency, awarded a Blanket Purchase Agreement (BPA) call contract to C.A.S.E.T. Associates, LTD. (UEI: CVHFDB52ZZ76) on May 12, 2016, with a ceiling value of $9,120.00. This firm fixed-price contract was executed without a set-aside designation and is scheduled for ultimate completion on May 17, 2016. The place of performance is located in Bethesda, Maryland, which serves as the headquarters for the National Cancer Institute. As a BPA call, this...
- The National Cancer Institute (NCI) awarded a $35.0 million Delivery Order to Leidos Biomedical Research Inc., a Federally Funded Research and Development Center (FFRDC) contractor, on August 31, 2019, under the FFRDC Moonshot Portfolio Task Order. The contract operates on a Cost Plus Fixed Fee basis with no set-aside designation and an ultimate completion date of September 30, 2026. Work is performed at the contractor's Frederick, Maryland facility. As an FFRDC operator for the NCI, Leidos...
- The National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health, awarded a firm fixed price blanket purchase agreement call contract valued at ninety-nine thousand eight hundred fifty-one dollars and forty cents ($99,851.40) to Kiliuda Consulting, LLC, an 8(a) small business concern, to provide support services to the Experimental Immunology Branch. Specifically, the contractor shall satisfy the overall operational objectives of the NCI...
- The National Cancer Institute awarded ICF Incorporated, L.L.C. a Blanket Purchase Agreement call valued at $1.17M under the Multiple Award Schedule contract vehicle, with a performance period concluding in February 2022. This firm-fixed-price contract supports communications initiatives across the NCI's broader audience engagement, including the Cancer.gov platform, NCI-wide communication-based programs, and activities aligned with the NCI Cancer Moonshot initiative. The work is to be...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,000 firm fixed price purchase order to Caerus US 1 Inc. for SOFTWARE. The place of performance is New York, NY. The one year contract starts on July 26, 2023 and ends on July 25, 2024. No set aside designation or subcontractors were identified. The National Cancer Institute is a part of NIH focused on cancer research, so this contract is likely to deliver software products or...